This information was published on 2025-02-14T16:27:27 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2519342 (IR 1836469) |
| (220) |
19 Dec 2024
|
| (300) |
US, 04 Jul 2024, 98633825
|
| (511) (510) |
Class 5
Pharmaceuticals for the treatment of immune and inflammatory disease; pharmaceutical products for immunotherapy, the treatment of inflammatory diseases, and the treatment infectious diseases. Class 35 New product commercialization services. Class 42 Drug discovery services: pharmaceutical research and development; provision of medical research and scientific research services and information in the field of pharmaceuticals, immune and inflammatory diseases, and clinical trials; medical research in the field of antibody-based therapies; medical research services in the fields of immunotherapy and inflammatory diseases. |
| (540) | BELENOS |
| (550) | Word |
| (730) |
Belenos Biosciences, Inc.
|
Find out more about publications on the About page.